Biotech, Pharmaceutical and Clinical Research Jobs | BioSpace

Pictured: 3D illustration of an RNA molecule/iStoc

Ipsen, Skyhawk Ink Potential $1.8B Deal to Target RNA in Neuro Diseases

Ipsen is looking to deepen its expertise in movement disorders in a research collaboration with Skyhawk Therapeutics to develop small molecule drugs for RNA targets in neurological diseases.

Pictured: Boehringer Ingelheim's headquarters in S

Boehringer, Ochre Bio Team in Potential $1B Deal to Develop Regenerative Liver Drugs

Boehringer Ingelheim is paying $35 million in upfront and near-term fees to work with Ochre Bio to identify and validate regenerative targets for metabolic dysfunction-associated steatohepatitis and other chronic liver diseases.

Pictured: Bristol Myers Squibb office in Brisbane,

BMS Taps Cellares in $380M CAR T Cell Therapy Manufacturing Agreement

Pictured: a collage of white blood cells and cance

23andMe, Innate Pharma Tap Antibodies to Target NK Cells for Cancer

Pictured: Collage of a brain and stem cells/Taylor

Early Data Indicate Cell Therapies Could ‘Reset the Clock’ in Parkinson’s

More Top Stories

View all Featured Employers

Bioversity graduate Josiah Wade-Green uses a pipet

Bioversity Program Preps Grads for Early-Career Life Science Roles

Pictured: Woman stressed with possible layoff/Tayl

How to Deal With Layoff-Related Stress

Pictured: Professional versus messy appearance for

Career Coach: How to Look Professional in Virtual Meetings

Pictured: 3D illustration of an RNA molecule/iStoc

4/22/2024

Ipsen, Skyhawk Ink Potential $1.8B Deal to Target RNA in Neuro Diseases

Pictured: Boehringer Ingelheim's headquarters in S

4/22/2024

Boehringer, Ochre Bio Team in Potential $1B Deal to Develop Regenerative Liver Drugs

Pictured: Bristol Myers Squibb office in Brisbane,

4/22/2024

BMS Taps Cellares in $380M CAR T Cell Therapy Manufacturing Agreement

Pictured: a collage of white blood cells and cance

4/22/2024

23andMe, Innate Pharma Tap Antibodies to Target NK Cells for Cancer

Pictured: Collage of a brain and stem cells/Taylor

4/22/2024

Early Data Indicate Cell Therapies Could ‘Reset the Clock’ in Parkinson’s

View all Hotbeds

Pictured: a collage of white blood cells and cance

4/22/2024

23andMe, Innate Pharma Tap Antibodies to Target NK Cells for Cancer

Pictured: Collage of a brain and stem cells/Taylor

4/22/2024

Early Data Indicate Cell Therapies Could ‘Reset the Clock’ in Parkinson’s

Pictured: Human torso highlighting the liver with

4/22/2024

Opinion: Akero and Madrigal Face Off in the MASH Space

Pictured: Doctor looking at a patient's brain scan

4/22/2024

AbbVie, NeuroDerm Heat Up Levodopa Competition with New Data at AAN24

Biopharma Layoff Tracker 2024: Pfizer, Sanofi, Vedanta and More Cut Staff

Pictured: Facade of Sanofi's headquarters in Franc

Sanofi Cuts Jobs in US Vaccines Division as Part of Restructuring

Pictured: 3D illustration of an RNA molecule/iStoc

Ipsen, Skyhawk Ink Potential $1.8B Deal to Target RNA in Neuro Diseases

Pictured: Boehringer Ingelheim's headquarters in S

Boehringer, Ochre Bio Team in Potential $1B Deal to Develop Regenerative Liver Drugs

2024 Employment Outlook Report

Recruiting with AI: Trends and Challenges in Life Sciences

Recruiting with AI: Trends and Challenges in Life Sciences

U.S. Life Sciences Salary Report

Best Places to Work in Biopharma